Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research.
Hoellwerth, M; Koelblinger, P; Lang, R; Harrer, A;
Life (Basel). 2023; 13(2):
Reviews

Experimental laboratory biomarkers in multiple sclerosis.
Arneth, B; Kraus, J;
Wien Med Wochenschr. 2022; 172(15-16): 346-358.
Reviews

Peripheral neuropathy due to neuroborreliosis: Insensitivity for CXCL13 as early diagnostic marker.
Gubanova, K; Lang, JL; Latzko, J; Novotna, B; Perneczky, J; Pingitzer, S; Purer, P; Wuchty, B; Waiss, C; Sellner, J
INT J INFECT DIS. 2021; 105: 460-462.
Case Reports

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
Harrer, C; Otto, F; Pilz, G; Haschke-Becher, E; Trinka, E; Hitzl, W; Wipfler, P; Harrer, A
FLUIDS BARRIERS CNS. 2021; 18(1): 40
Full papers/articles (Journal)

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.
Pilz, G; Sakic, I; Wipfler, P; Kraus, J; Haschke-Becher, E; Hitzl, W; Trinka, E; Harrer, A;
Fluids Barriers CNS. 2020; 17(1): 7
Full papers/articles (Journal)

Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.
Pilz, G; Steger, R; Wipfler, P; Otto, F; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroimmunol. 2020; 338:577087
Full papers/articles (Journal)

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.
Pilz, G; Wipfler, P; Otto, F; Hitzl, W; Afazel, S; Haschke-Becher, E; Trinka, E; Harrer, A;
J Neuroinflammation. 2019; 16(1): 13
Full papers/articles (Journal)

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Kowarik, MC; Cepok, S; Sellner, J; Grummel, V; Weber, MS; Korn, T; Berthele, A; Hemmer, B;
J Neuroinflammation. 2012; 9 (93): 1-11.
Full papers/articles (Journal)